Targeting lipid biosynthesis pathways for hepatitis B virus cure
Chronic hepatitis B virus (HBV) infection is characterized by the presence of high circulating levels of non-infectious lipoprotein-like HBV surface antigen (HBsAg) particles thought to contribute to chronic immune dysfunction in patients. Lipid and metabolomic analysis of humanized livers from immu...
Main Authors: | Anastasia Hyrina, Dara Burdette, Zhijuan Song, Ricardo Ramirez, Ayse Okesli-Armlovich, Archana Vijayakumar, Jamie Bates, James L. Trevaskis, Simon P. Fletcher, William A. Lee, Meghan M. Holdorf |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352027/?tool=EBI |
Similar Items
-
Targeting lipid biosynthesis pathways for hepatitis B virus cure.
by: Anastasia Hyrina, et al.
Published: (2022-01-01) -
Combinations of an acetyl CoA carboxylase inhibitor with hepatic lipid modulating agents do not augment antifibrotic efficacy in preclinical models of NASH and fibrosis
by: Archana Vijayakumar, et al.
Published: (2022-09-01) -
Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9
by: Anastasia Hyrina, et al.
Published: (2017-09-01) -
A Genome-wide CRISPR Screen Identifies ZCCHC14 as a Host Factor Required for Hepatitis B Surface Antigen Production
by: Anastasia Hyrina, et al.
Published: (2019-12-01) -
Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cells
by: Jan-Hendrik Bockmann, et al.
Published: (2025-03-01)